Physical consequences of schizophrenia and its treatment - The metabolic syndrome

被引:179
作者
Ryan, MCM [1 ]
Thakore, JH [1 ]
机构
[1] St Vincents Hosp, Ctr Neurosci, Dublin 3, Ireland
关键词
metabolic syndrome; insulin; cortisol; schizophrenia; morbidity; mortality; visceral fat; abdominal obesity; diabetes; cardiovascular; dyslipidaemia; neuroleptic; medication; sympathetic; autonomic;
D O I
10.1016/S0024-3205(02)01646-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Schizophrenia is a life shortening illness. Unnatural causes and natural causes are put forward as reasons for this excess mortality. In terms of the latter, a host of different physical disorders occur with increased frequency in schizophrenia. When taken together, some of these illnesses such as type 2 diabetes mellitus and cardiovascular disorders constitute the Metabolic Syndrome; a characteristic phenotype of those with this syndrome is excessive visceral fat distribution. The exact reasons why this particular syndrome occurs in schizophrenia is as yet unclear though factors such as life style, poor diet and lack of exercise may contribute to it's development. Alternatively, overactivity of the hypothalamic-pituitary-adrenal axis leading to hypercortisolaemia can also result in excessive visceral fat accumulation. This minireview aims to explore the potential role of these issues and medication in terms of the increased morbidity and mortality observed in schizophrenia. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:239 / 257
页数:19
相关论文
共 148 条
[1]  
ALLEBECK P, 1986, ARCH GEN PSYCHIAT, V43, P650
[2]   The distribution of body mass index among individuals with and without schizophrenia [J].
Allison, DB ;
Fontaine, KR ;
Heo, M ;
Mentore, JL ;
Cappelleri, JC ;
Chandler, LP ;
Weiden, PJ ;
Cheskin, LJ .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (04) :215-220
[3]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[4]  
ALRA A, 1991, CIRCULATION, V83, P1888
[5]  
ALSTROM CH, 1942, ACTA PSYCHIAT NE S42
[6]   DEXAMETHASONE SUPPRESSION TEST IN POSITIVE AND NEGATIVE SCHIZOPHRENIA [J].
ALTAMURA, C ;
GUERCETTI, G ;
PERCUDANI, M .
PSYCHIATRY RESEARCH, 1989, 30 (01) :69-75
[7]  
ARITA M, 1973, J PHARMACOL EXP THER, V184, P619
[8]  
Aruna, 1995, J Assoc Physicians India, V43, P146
[9]  
AXELSSON R, 1982, J CLIN PSYCHIAT, V43, P332
[10]   ELECTROCARDIOGRAPHIC CHANGES INDUCED BY PHENOTHIAZINE DRUGS [J].
BAN, TA ;
STJEAN, A .
AMERICAN HEART JOURNAL, 1965, 70 (04) :575-&